Novartis: No Aliskiren Benefit In Heart Attacks
Source: Fox Business
Tuesday 16th March, 2010
LONDON -- Novartis said a study showed that its aliskiren cardiovascular medicine didn't show a statistically significant benefit when added to standard therapy for patients recovering from a heart a... ...
Read the full story at
Fox Business
Email this story to a friend
Have your say on this story